Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p- dioxin-induced cytochrome P450 1B1 expression in human lymphocytes

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 2, 1999, Pages 139-146

  Spencer, Diane L ^a   Masten, Scott A ^a   Lanier, Karah M ^a   Yang, Xinping ^a   Grassman, Jean A ^a   Miller, Chris R ^a   Sutter, Thomas R ^b   Lucier, George W ^a   Walker, Nigel J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; BIOLOGICAL MARKER; CYTOCHROME P450; RNA;

ARTICLE; ENZYME INDUCTION; EPIDEMIOLOGY; HUMAN; HUMAN CELL; LYMPHOCYTE; MOLECULAR BIOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ARYL HYDROCARBON HYDROXYLASES; BIOLOGICAL MARKERS; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; EPIDEMIOLOGY, MOLECULAR; ESTRADIOL; ESTROGENS, CATECHOL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; MITOGENS; RNA; TETRACHLORODIBENZODIOXIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0033016088     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC Monogr. Eval. Carcinog. Risks Hum., 69: 1-631, 1997.
2. Schecter, A., Furst, P., Furst, C., Papke, O., Ball, M., Ryan, J. J., Hoang, D. C., Le, C. D., Hoang, T. Q., Cuong, H. Q., Nguyen, T. N. P., Pham, H. P., Beim, A., Constable, J., Startin, J., Samedy, M., and Yit, K. S. Chlorinated dioxins and dibenzofurans in human tissue from general populations: a selective review. Environ. Health Perspect., 102 (Suppl. 1): 159-171, 1994.
3. Kogevinas, M., Becher, H., Benn, T., Bertazzi, P. A., Boffetta, P., Bueno de Mesquita, H. B., Coggon, D., Colin, D., Flesch Janys, D., Fingerhut, M., Green, L., Kauppinen, T., Littorin, M., Lynge, E., Mathews, J. D., Neuberger, M., Pearce, N., and Saracci, R. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am. J. Epidemiol., 145: 1061-1075, 1997.
4. Bertazzi, P. A., Zocchetti, C., Guercilena, S., Consonni, D., Tironi, A., Landi, M. T., and Pesatori, A. C. Dioxin exposure and cancer risk: a 15-year mortality study after the "Seveso accident." Epidemiology, 8: 646-652, 1997.
5. Schmidt, J. V., and Bradfield, C. A. Ah receptor signaling pathways. Annu. Rev. Cell. Dev. Biol., 12: 55-89, 1996.
6. Poland, A., and Knutson, J. C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol., 22: 517-554, 1982.
7. Whitlock, J. P., Jr., Cooper, H. L., and Gelboin, V. H. Aryl hydrocarbon (benzopyrene) hydroxylase is stimulated in human lymphocytes by mitogens and benz(a)anthracene. Science (Washington DC), 177: 618-619, 1972.
8. Busbee, D. L., Shaw, C. R., and Cantrell, E. T. Aryl hydrocarbon hydroxylase induction in human leukocytes. Science (Washington DC), 178: 315-316, 1972.
9. Okey, A. B., Riddick, D. S., and Harper, P. A. The Ah receptor: Mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett., 70: 1-22, 1994.
10. Vanden Heuvel, J. P., Clark, G. C., Thompson, C. L., McCoy, Z., Miller, C. R., Lucier, G. W., and Bell, D. A. CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis (Lond.), 14: 2003-2006, 1993.
11. Kellermann, G., Shaw, C. R., and Luyten-Kellerman, M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med., 289: 934-937, 1973.
12. Cosma, G. N., Toniolo, P., Currie, D., Pasternack, B. S., and Garte, S. J. Expression of the CYP1A1 gene in peripheral lymphocytes as a marker of exposure to creosote in railroad workers. Cancer Epidemiol. Biomarkers Prev., 1: 137-142, 1992.
13. Grassman, J. A., Masten, S. A., Walker, N. J., and Lucier, G. W. Animal models of human response to dioxins. Environ. Health Perspect., 106 (Suppl. 2): 761-775, 1998.
14. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y.-Y. P., Jabs, E. W., Li, X., Ying, H., Cody, C. W., and Greenlee, W. F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem., 269: 13092-13099, 1994.
15. Walker, N. J., Gastel, J. A., Costa, L. T., Clark, G. C., Lucier, G. W., and Sutter, T. R. Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis (Lond.), 16: 1319-1327, 1995.
16. Sutter, T. R., Guzman, K., Dold, K. M., and Greenlee, W. F. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1β. Science (Washington DC), 254: 415-418, 1991.
17. Savas, U., Bhattacharyya, K. K., Christou, M., Alexander, D. L., and Jefcoate, C. R. Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression. J. Biol. Chem., 269: 14905-14911, 1994.
18. Bhattacharyya, K. K., Brake, P. B., Eltom, S. E., Otto, S. A., and Jefcoate, C. R. Identification of a rat adrenal cytochrome P450 active in polycyclic hydrocarbon metabolism as rat CYP1B1. Demonstration of a unique tissue-specific pattern of hormonal and aryl hydrocarbon receptor-linked regulation. J. Biol. Chem., 270: 11595-11602, 1995.
19. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., and Sutter, T. R. 17β-Estradiol hydroxylation catalyzed by human cylochrome P450 1B1. Proc. Natl. Acad. Sci. USA, 93: 9776-9781, 1996.
20. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res., 56: 2979-2984, 1996.
21. Shimada, T., Gillam, E. M., Sutter, T. R., Strickland, P. T., Guengerich, F. P., and Yamazaki, H. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab. Dispos., 25: 617-622, 1997.
22. Liehr, J. G., Ricci, M. J., Jefcoate, C. R., Hannigan, E. V., Hokanson, J. A., and Zhu, B. T. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc. Natl. Acad. Sci. USA, 92: 9220-9224, 1995.
23. Liehr, J. G., and Ricci, M. J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA, 93: 3294-3296, 1996.
24. Clark, G., Tritscher, A., Bell, D., and Lucier, G. Integrated approach for evaluating species and interindividual differences in responsiveness to dioxins and structural analogs. Environ. Health Perspect., 98: 125-132, 1992.
25. Masten, S. A., Grassman, J. A., Yang, X., Miller, C. R., Spencer, D. L., Lanier, K. M., Walker, N. J., Jung, D., Konietzko, J., Edler, L., Patterson, D. G., Needham, L. L., and Lucier, G. W. Mechanistically based markers of exposure and response to dioxin in occupationally exposed individuals. Organohalogen Compounds, 34: 80-85, 1997.
26. Tucker, A. N., Vore, S. J., and Luster, M. I. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol., 29: 372-377, 1986.
27. Vanden Heuvel, J. P., Tyson, F. L., and Bell, D. A. Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques, 14: 395-398, 1993.
28. Vanden Heuvel, J. P., Clark, G. C., Kohn, M. C., Tritscher, A. M., Greenlee, W. F., Lucier, G. W., and Bell, D. A. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res., 54: 62-68, 1994.
29. Tang, Y. M., Wo, Y. Y. P., Stewart, J., Hawkins, A. L., Griffin, C. A., Sutter, T. R., and Greenlee, W. F. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J. Biol. Chem., 271: 28324-28330, 1996.
30. Holford, N. H. G., and Scheiner, L. B. Pharmacokinetic and pharmacodynamic modeling in vivo. CRC Crit. Rev. Bioeng., 5: 273-322, 1981.
31. Spink, D. C., Hayes, C. L., Young, N. R., Christou, M., Sutter, T. R., Jefcoate, C. R., and Gierthy, J. F. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17β-estradiol 4-hydroxylase. J. Steroid. Biochem. Mol. Biol., 51: 251-258, 1994.
32. Larsen, M. C., Angus, W. G., Brake, P. B., Eltom, S. E., Sukow, K. A., and Jefcoate, C. R. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Res., 58: 2366-2374, 1998.
33. Eltom, S. E., Larsen, M. C. and Jefcoate, C. R. Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: role of the Ah receptor. Carcinogenesis (Lond.), 19: 1437-1444, 1998.
34. Stoilov, I., Akarsu, A. N., Alozie, I., Child, A., Barsoum-Homsy, M., Turacli, M. E., Or, M., Lewis, R. A., Ozdemir, N., Brice, G., Aktan, S. G., Chevrette, L., Coca-Prados, M., and Sarfarazi, M. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am. J. Hum. Genet., 62: 573-584, 1998.
35. Baron, J. M., Jugert, F. K., Zwadlo-Klarwasser, G., Jugert, F., Hamann, W., Rubben, A., Mukhtar, H., and Merk, H. F. Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem. Pharmacol., 56: 1105-1110, 1998.